Bandgrip vs Traditional Sutures TJA
Primary Purpose
Osteoarthritis
Status
Suspended
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Bandgrip Micro-Anchor Wound Closure
Suture closure
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Subject is male or female greater than 18 years of age
- Scheduled to undergo primary total knee or total hip replacement
- Able to read and comprehend informed consent form and comply with the follow-up evaluation schedule
Exclusion Criteria:
- Prior surgical incision or scar in close proximity of the proposed incision (<2 cm).
- Local skin conditions such as dermatitis, eczema, or psoriasis.
- Active or previous infection in the skin or the hip or knee to be operated.
- Inflammatory arthritis; connective tissue or vascular disorders or diseases that would adversely affect wound healing including the use of oral or topical corticosteroid use
- Subject has a recent history of bleeding, coagulation and/or clotting disorders
- Subject has a known allergy to BandGrip material (polycarbonate)
Sites / Locations
- Rothman Orthopaedics
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Bandgrip Micro-Anchor Skin Closure
Standard of Care wound closure
Arm Description
Standard Monocryl suture closure
Outcomes
Primary Outcome Measures
Number of patients with wound healing complications
All wound-related complication following surgery
Secondary Outcome Measures
Closure time of surgical wound
Time (in seconds) that it takes to close the incisional wound during surgery
Full Information
NCT ID
NCT05166642
First Posted
December 7, 2021
Last Updated
September 7, 2023
Sponsor
Center for Innovation and Research Organization
1. Study Identification
Unique Protocol Identification Number
NCT05166642
Brief Title
Bandgrip vs Traditional Sutures TJA
Official Title
Prospective, Randomized Clinical Trial Assessing Post-operative Wound Healing Complications Following Total Joint Arthroplasty When Using Bandgrip Incision Closure Compared to Standard Suture Closure
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Suspended
Why Stopped
Temporary hold on recruitment
Study Start Date
March 8, 2021 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
January 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Center for Innovation and Research Organization
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
Total Joint Arthroplasty (TJA) has become one of the most performed elective procedures. While the results of this procedure are often consistent with high patient satisfaction and return-to-function, wound-related complications can contribute to high-cost "bundle busters". Following surgery, wound drainage or other wound complications can lead to increased cost and decreased patient satisfaction. Secure wound closure is an important step in preventing wound-related complications. The surgical incision should be closed in a manner that prevents the wound edges from separating which could lead to possible drainage and bacterial contamination of the incision.
Traditional incision closure following TJA includes sutures. These sutures are then removed in the office. BandGrip is a wound closure device that can be used to approximate skin edges of wounds from surgical incisions and traumatic lacerations. It is a bandage-type patch with several small skin anchors that are used to hold the skin edges together. The clear microanchors are 0.029 inches in height and do not puncture through the dermis. There is no need for medical removal as the patient can remove the bandage.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Bandgrip Micro-Anchor Skin Closure
Arm Type
Active Comparator
Arm Title
Standard of Care wound closure
Arm Type
Active Comparator
Arm Description
Standard Monocryl suture closure
Intervention Type
Device
Intervention Name(s)
Bandgrip Micro-Anchor Wound Closure
Intervention Description
This treatment group will utilize a suture closure technique for the deep dermal layers with Bandgrip being applied to the most superficial layer of the surgical incision
Intervention Type
Device
Intervention Name(s)
Suture closure
Intervention Description
This treatment gourd will utilize suture closure technique for all layers of the surgical incision.
Primary Outcome Measure Information:
Title
Number of patients with wound healing complications
Description
All wound-related complication following surgery
Time Frame
From time of surgery to 30 days post-op
Secondary Outcome Measure Information:
Title
Closure time of surgical wound
Description
Time (in seconds) that it takes to close the incisional wound during surgery
Time Frame
Procedure (The time from the first skin pass with the suture needle until the time the last suture knot is tied will be recorded in seconds)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subject is male or female greater than 18 years of age
Scheduled to undergo primary total knee or total hip replacement
Able to read and comprehend informed consent form and comply with the follow-up evaluation schedule
Exclusion Criteria:
Prior surgical incision or scar in close proximity of the proposed incision (<2 cm).
Local skin conditions such as dermatitis, eczema, or psoriasis.
Active or previous infection in the skin or the hip or knee to be operated.
Inflammatory arthritis; connective tissue or vascular disorders or diseases that would adversely affect wound healing including the use of oral or topical corticosteroid use
Subject has a recent history of bleeding, coagulation and/or clotting disorders
Subject has a known allergy to BandGrip material (polycarbonate)
Facility Information:
Facility Name
Rothman Orthopaedics
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Bandgrip vs Traditional Sutures TJA
We'll reach out to this number within 24 hrs